The Relevance of External Quality Assessment for Molecular Testing for ALK Positive Non-Small Cell Lung Cancer: Results from Two Pilot Rounds Show Room for Optimization

• Lien Tembuyser,

  Affiliation Department of Public Health and Primary Care, Biomedical Quality Assurance Research Unit, KU Leuven – University of Leuven, Leuven, Belgium

  ⨯
• Véronique Tack,

  Affiliation Department of Public Health and Primary Care, Biomedical Quality Assurance Research Unit, KU Leuven – University of Leuven, Leuven, Belgium

  ⨯
• Karen Zwaenepoel,

  Affiliation Department of Pathology, Antwerp University Hospital, Edegem, Belgium

  ⨯
• Patrick Pauwels,

  Affiliation Department of Pathology, Antwerp University Hospital, Edegem, Belgium

  ⨯
• Keith Miller,

  Affiliation UK NEQAS ICC & ISH, London, United Kingdom

  ⨯
• Lukas Bubendorf,

  Affiliation Institute for Pathology, Basel University Hospital, Basel, Switzerland

  ⨯
• Keith Kerr,

  Affiliation Department of Pathology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom

  ⨯
• Ed Schuuring,

  Affiliation Department of Pathology and Medical Biology, University of Groningen, Groningen, the Netherlands

  ⨯
• Erik Thunnissen,

  Affiliation Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands

  ⨯
• Elisabeth M. C. Dequeker

  * E-mail: els.dequeker@med.kuleuven.be

  Affiliation Department of Public Health and Primary Care, Biomedical Quality Assurance Research Unit, KU Leuven – University of Leuven, Leuven, Belgium

  ⨯